Literature DB >> 15920146

Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation.

Amilcar S Damazo1, Simon Yona, Fulvio D'Acquisto, Roderick J Flower, Sonia M Oliani, Mauro Perretti.   

Abstract

The inflammatory response is a protective process of the body to counteract xenobiotic penetration and injury, although in disease this response can become deregulated. There are endogenous biochemical pathways that operate in the host to keep inflammation under control. Here we demonstrate that the counterregulator annexin 1 (AnxA1) is critical for controlling experimental endotoxemia. Lipopolysaccharide (LPS) markedly activated the AnxA1 gene in epithelial cells, neutrophils, and peritoneal, mesenteric, and alveolar macrophages--cell types known to function in experimental endotoxemia. Administration of LPS to AnxA1-deficient mice produced a toxic response characterized by organ injury and lethality within 48 hours, a phenotype rescued by exogenous application of low doses of the protein. In the absence of AnxA1, LPS generated a deregulated cellular and cytokine response with a marked degree of leukocyte adhesion in the microcirculation. Analysis of LPS receptor expression in AnxA1-null macrophages indicated an aberrant expression of Toll-like receptor 4. In conclusion, this study has detailed cellular and biochemical alterations associated with AnxA1 gene deletion and highlighted the impact of this protective circuit for the correct functioning of the homeostatic response to sublethal doses of LPS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920146      PMCID: PMC1602430          DOI: 10.1016/S0002-9440(10)62471-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  Corticosteroids inhibit lymphocyte binding to endothelium and intercellular adhesion: an additional mechanism for their anti-inflammatory and immunosuppressive effect.

Authors:  C Pitzalis; N Pipitone; G Bajocchi; M Hall; N Goulding; A Lee; G Kingsley; J Lanchbury; G Panayi
Journal:  J Immunol       Date:  1997-05-15       Impact factor: 5.422

Review 2.  Tissue destruction by neutrophils.

Authors:  S J Weiss
Journal:  N Engl J Med       Date:  1989-02-09       Impact factor: 91.245

3.  Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration.

Authors:  M Perretti; J D Croxtall; S K Wheller; N J Goulding; R Hannon; R J Flower
Journal:  Nat Med       Date:  1996-11       Impact factor: 53.440

4.  Measurement of lipocortin 1 levels in murine peripheral blood leukocytes by flow cytometry: modulation by glucocorticoids and inflammation.

Authors:  M Perretti; R J Flower
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

5.  Glucocorticoid receptor regulates expression of L-selectin and CD11/CD18 on human neutrophils.

Authors:  J G Filep; A Delalandre; Y Payette; E Földes-Filep
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

6.  Inhibition of O2- generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages.

Authors:  I Maridonneau-Parini; M Errasfa; F Russo-Marie
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

7.  Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line.

Authors:  J D Croxtall; R J Flower
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

8.  Detection of intracellular lipocortin 1 in human leukocyte subsets.

Authors:  E F Morand; P Hutchinson; A Hargreaves; N J Goulding; N W Boyce; S R Holdsworth
Journal:  Clin Immunol Immunopathol       Date:  1995-08

9.  Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat.

Authors:  C C Wu; J D Croxtall; M Perretti; C E Bryant; C Thiemermann; R J Flower; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

10.  Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.

Authors:  C J Fisher; J M Agosti; S M Opal; S F Lowry; R A Balk; J C Sadoff; E Abraham; R M Schein; E Benjamin
Journal:  N Engl J Med       Date:  1996-06-27       Impact factor: 91.245

View more
  47 in total

1.  A most important annexation.

Authors:  Brian A Babbin; Andrew T Gewirtz
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

Review 2.  Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics.

Authors:  Mauro Perretti; Jesmond Dalli
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

3.  Annexin A1 regulates intestinal mucosal injury, inflammation, and repair.

Authors:  Brian A Babbin; Mike G Laukoetter; Porfirio Nava; Stefan Koch; Winston Y Lee; Christopher T Capaldo; Eric Peatman; Eric A Severson; Roderick J Flower; Mauro Perretti; Charles A Parkos; Asma Nusrat
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

4.  Age-related response to an acute innate immune challenge in mice: proteomics reveals a telomere maintenance-related cost.

Authors:  François Criscuolo; Gabriele Sorci; Margaux Behaim-Delarbre; Sandrine Zahn; Bruno Faivre; Fabrice Bertile
Journal:  Proc Biol Sci       Date:  2018-12-05       Impact factor: 5.349

5.  The role of annexin A1 in the modulation of the NLRP3 inflammasome.

Authors:  Izabela Galvão; Renan V H de Carvalho; Juliana P Vago; Alexandre L N Silva; Toniana G Carvalho; Maísa M Antunes; Fabiola M Ribeiro; Gustavo B Menezes; Dario S Zamboni; Lirlândia P Sousa; Mauro M Teixeira
Journal:  Immunology       Date:  2020-03-30       Impact factor: 7.397

6.  Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair.

Authors:  Giovanna Leoni; Ashfaqul Alam; Philipp-Alexander Neumann; J David Lambeth; Guangjie Cheng; James McCoy; Roland S Hilgarth; Kousik Kundu; Niren Murthy; Dennis Kusters; Chris Reutelingsperger; Mauro Perretti; Charles A Parkos; Andrew S Neish; Asma Nusrat
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

7.  Downstream gene activation of the receptor ALX by the agonist annexin A1.

Authors:  Derek Renshaw; Trinidad Montero-Melendez; Jesmond Dalli; Ahmad Kamal; Vincenzo Brancaleone; Fulvio D'Acquisto; Giuseppe Cirino; Mauro Perretti
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

8.  Modulation of experimental autoimmune encephalomyelitis by endogenous annexin A1.

Authors:  Nikolaos Paschalidis; Asif J Iqbal; Francesco Maione; Elisabeth G Wood; Mauro Perretti; Rod J Flower; Fulvio D'Acquisto
Journal:  J Neuroinflammation       Date:  2009-11-13       Impact factor: 8.322

9.  Dexamethasone modulates Salmonella enterica serovar Typhimurium infection in vivo independently of the glucocorticoid-inducible protein annexin-A1.

Authors:  Tomoko Smyth; Sabine Tötemeyer; Sean Haugland; Chrissie Willers; Sarah Peters; Duncan Maskell; Clare Bryant
Journal:  FEMS Immunol Med Microbiol       Date:  2008-12

10.  Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1.

Authors:  Samia Yazid; Egle Solito; Helen Christian; Simon McArthur; Nicolas Goulding; Roderick Flower
Journal:  Biochem Pharmacol       Date:  2009-03-24       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.